Anti-Human CD20 Therapeutic Antibody (Tositumomab)
Recombinant monoclonal antibody to Human CD20. Tositumomab is a drug for the treatment of follicular lymphoma. It is an IgG2a anti-CD20 monoclonal antibody derived from immortalized mouse cells. Tositumomab is applied in a sequential infusion followed by iodine (131I) tositumomab, which is the same antibody covalently bound to the radionuclide iodine-131 (131I). 131I emits both beta and gamma radiation and decays with a half-life of 8 days.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-017 |
| Pricing | Inquiry |
| Host | Mouse |
| Target | CD20 |
| Species Reactivity | Human |
| Type | IgG2a - lambda |
| Applications | Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, ICC and most other immunological methods. |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |